https://reopen.europa.eu/en<\/a><\/p> <\/p>
The list includes all vaccines administered in the United Kingdom, including all batches of AstraZeneca vaccine administered in the UK known commercially as Vaxzevria. This also includes batches 4120Z001, 4120Z002 and 4120Z003. Decisions on which vaccines EU Member States will accept at their borders is for those countries to decide. We are not aware that any have decided not to accept UK vaccines.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-09-07", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-09-07T15:15:23.27Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-08-18", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Travel: Coronavirus"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that people who have received two covid-19 vaccinations, including Oxford AstraZeneca batch numbers (a) 4120Z001, (b) 4120Z002 and (c) 4120Z003, are able to travel to EU countries.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4472", "label" : {"_value" : "Biography information for Holly Lynch"}
}
, "tablingMemberConstituency" : {"_value" : "Halifax"}
, "tablingMemberPrinted" : [{"_value" : "Holly Lynch"}
], "uin" : "41025"}
, {"_about" : "http://data.parliament.uk/resources/1351014", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1351014/answer", "answerText" : {"_value" : "
The Serum Institute of India (SII) manufactures both Vaxzevria and Covishield vaccines and both branded vaccines are exactly the same COVID-19 AstraZeneca vaccine. All SII-made doses approved by the United Kingdom (UK) regulator, the Medicines and Healthcare Products Regulatory Agency (MHRA) and administered in the UK were branded as the \u2019COVID-19 vaccine AstraZeneca\u2019 which is now known commercially as \u2018Vaxzevria\u2019.<\/p>
<\/p>
The government continues to liaise with counterparts in Italy and we are seeking Italian confirmation that they will recognise all AstraZeneca doses administered in the UK. We will ensure that Foreign, Commonwealth and Development Office Travel Advice is kept up to date following any developments.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-09-07", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-09-07T15:10:14.127Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-08-18", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Travel: Coronavirus"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what discussions his Department has had with its counterpart in Italy in respect of British tourists' entry to Italy whose covid-19 vaccine was manufactured at Serum Institute in India.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4818", "label" : {"_value" : "Biography information for Saqib Bhatti"}
}
, "tablingMemberConstituency" : {"_value" : "Meriden"}
, "tablingMemberPrinted" : [{"_value" : "Saqib Bhatti"}
], "uin" : "41357"}
, {"_about" : "http://data.parliament.uk/resources/1351023", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1351023/answer", "answerText" : {"_value" : "
The Government is currently undertaking extensive work to consider which regulators and associated vaccines we would recognise. It is important to consider which regulators have similar stringent standards of authorisation as the Medicines Healthcare products Regulatory Agency, which has some of the highest standards of quality, safety and efficacy in the world. This will then feed into discussions regarding quarantine from amber-listed countries.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-09-07", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-09-07T15:22:34.897Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-08-18", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Travel: Quarantine"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, for what reason Government policy makes a distinction between covid-19 vaccines received in the UK and those received overseas when deciding whether a traveller returning from an amber list country needs to quarantine.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4682", "label" : {"_value" : "Biography information for Luke Pollard"}
}
, "tablingMemberConstituency" : {"_value" : "Plymouth, Sutton and Devonport"}
, "tablingMemberPrinted" : [{"_value" : "Luke Pollard"}
], "uin" : "41240"}
, {"_about" : "http://data.parliament.uk/resources/1351024", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1351024/answer", "answerText" : {"_value" : "
Comparisons between vaccines administered across the world are complex due to differences in vaccine trials and monitoring. When a vaccine receives a marketing authorisation or conditional marketing authorisation from a medicines regulator, certain factors or conditions are specified by the national regulator in order to ensure the product is of the highest quality, safety and efficacy for authorisation.<\/p>
We are currently considering which regulators and associated vaccines we would be confident to recognise in the United Kingdom.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-09-07", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-09-07T15:06:24.84Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-08-18", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, whether there is a material difference in terms of (a) medical and (b) public health effect between covid-19 vaccines administered overseas and those administered domestically by the NHS.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4682", "label" : {"_value" : "Biography information for Luke Pollard"}
}
, "tablingMemberConstituency" : {"_value" : "Plymouth, Sutton and Devonport"}
, "tablingMemberPrinted" : [{"_value" : "Luke Pollard"}
], "uin" : "41241"}
, {"_about" : "http://data.parliament.uk/resources/1351044", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1351044/answer", "answerText" : {"_value" : "
The Government has regularly engaged with multiple stakeholders including the Department for Transport, manufacturers and automotive trade associations to discuss steps to help rectify supply chain shortages.<\/p>
<\/p>
The Government recognises the severity of the semiconductor shortage and its impacts on vehicle supply chains. BEIS officials are working with the Department for Digital, Culture, Media and Sport (DCMS) who are leading on this issue. DCMS is working closely with companies affected by this shortage to discuss interim support measures and supply solutions, as well as lobbying for a coordinated multilateral response through the G7. DCMS is also engaging bilaterally with key supplier countries like the US and Japan, to lobby for fair UK access to currently constrained supply and address systemic issues in the sector to avoid future repetition of the current shortage.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-09-13", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-09-13T12:56:58.74Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "201"}
, "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"}
, "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"}
, "date" : {"_value" : "2021-08-18", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Vans: Manufacturing Industries"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, what recent assessment he has made of vehicle supply shortages affecting the UK van sector; and what cross-departmental steps he is taking to help rectify those supply shortages.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4511", "label" : {"_value" : "Biography information for Dr Rupa Huq"}
}
, "tablingMemberConstituency" : {"_value" : "Ealing Central and Acton"}
, "tablingMemberPrinted" : [{"_value" : "Dr Rupa Huq"}
], "uin" : "41074"}
, {"_about" : "http://data.parliament.uk/resources/1351056", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1351056/answer", "answerText" : {"_value" : "
The Government is investing £2.8 billion to support the transition to zero emission vehicles, including to support the uptake of zero and ultra low emission cars, vans, trucks, motorcycles, taxis and buses, as well funding\u202fto support charge point infrastructure at homes,\u202fworkplaces,\u202fon residential streets\u202fand across the wider roads network, to make charging as easy as refuelling a petrol or diesel car.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-09-09", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-09-09T13:11:15.317Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "201"}
, "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"}
, "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"}
, "date" : {"_value" : "2021-08-18", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Motor Vehicles: Waste Disposal"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, whether his Department has made an assessment of the potential merits of introducing a dedicated scrapping system for diesel and petrol vehicles ahead of the transition towards zero emission vehicles by 2030.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4786", "label" : {"_value" : "Biography information for Zarah Sultana"}
}
, "tablingMemberConstituency" : {"_value" : "Coventry South"}
, "tablingMemberPrinted" : [{"_value" : "Zarah Sultana"}
], "uin" : "41316"}
, {"_about" : "http://data.parliament.uk/resources/1351060", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1351060/answer", "answerText" : {"_value" : "
The Joint Committee on Vaccination and Immunisation (JCVI) published interim advice on a potential Covid-19 booster vaccination programme on 30th June 2021 which can be found at the following link:<\/p>
<\/p>
https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022/jcvi-interim-advice-potential-covid-19-booster-vaccine-programme-winter-2021-to-2022<\/a><\/p> <\/p>
The JCVI\u2019s interim advice is that COVID-19 boosters are first offered to the most vulnerable. They advise a two-staged approach, with individuals in Stage 1 offered a COVID-19 booster vaccine as well as a flu vaccine, as soon as possible from September 2021, and individuals in Stage 2 offered a COVID-19 booster vaccine as soon as practicable after Stage 1, with equal emphasis on deployment of the flu vaccine where eligible. Adults aged over 50 years old, and those aged between 16 and 49 who are in an influenza or COVID-19 at-risk group, are included in Stage 2.<\/p>
It is important to note that the JCVI\u2019s advice is interim to inform planning, and this may be subject to change.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-09-06", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-09-06T11:45:22.607Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-08-18", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, whether NHS England plans to use the flu vaccine list to prioritise patients, including those with asthma, for the covid-19 booster vaccination.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/413", "label" : {"_value" : "Biography information for Hilary Benn"}
}
, "tablingMemberConstituency" : {"_value" : "Leeds Central"}
, "tablingMemberPrinted" : [{"_value" : "Hilary Benn"}
], "uin" : "40603"}
, {"_about" : "http://data.parliament.uk/resources/1351082", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1351082/answer", "answerText" : {"_value" : "
Last winter, the seasonal flu programme was extended on 1 December 2020 to include those aged 50 to 64 years old who were not in a clinical risk group. Of this group, 35.2% were vaccinated by the end of the season, with an estimated 2,669,568 vaccinations given.<\/p>
For the 2021/22 flu season, we will continue to vaccinate all 50 to 64 year olds and will build on record uptake rates from the 20/21 winter. As a result of earlier advice from the Joint Committee on Vaccination and Immunisation and building on lessons learnt, 50 to 64 year olds will be eligible to book their appointment from the beginning of the season to allow more people to get vaccinated earlier.<\/p>
In total, over 35 million people will be eligible for a free seasonal flu vaccine this year. The Department is in regular contact with flu vaccine manufacturers to ensure there is a sufficient amount of flu vaccines available to meet uptake ambitions for eligible cohorts.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-09-06", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "40613"}
, {"_value" : "40614"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-09-06T11:36:34.09Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-08-18", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Influenza: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the effect of the expansion of eligibility for flu vaccination to the over 50s in (a) 2020-21 and (b) 2021-22.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/429", "label" : {"_value" : "Biography information for Derek Twigg"}
}
, "tablingMemberConstituency" : {"_value" : "Halton"}
, "tablingMemberPrinted" : [{"_value" : "Derek Twigg"}
], "uin" : "40611"}
], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&max-dateTabled=2021-08-18&answer.answeringMemberConstituency=Stratford-on-Avon&min-ddpModified.=2020-12-30T15%3A46%3A11.159Z", "page" : 0, "startIndex" : 1, "totalResults" : 1491, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}